Logo image of ALHRS.PA

HYDROGEN REFUELING SOLUTIONS (ALHRS.PA) Stock Fundamental Analysis

EPA:ALHRS - Euronext Paris - Matif - FR0014001PM5 - Common Stock - Currency: EUR

4.09  -0.02 (-0.49%)

Fundamental Rating

2

ALHRS gets a fundamental rating of 2 out of 10. The analysis compared the fundamentals against 104 industry peers in the Machinery industry. ALHRS may be in some trouble as it scores bad on both profitability and health. While showing a medium growth rate, ALHRS is valued expensive at the moment.


Dividend Valuation Growth Profitability Health

Quickly go to:

0

1. Profitability

1.1 Basic Checks

ALHRS had negative earnings in the past year.
ALHRS had a negative operating cash flow in the past year.
ALHRS had negative earnings in each of the past 5 years.
ALHRS had a negative operating cash flow in each of the past 5 years.
ALHRS.PA Yearly Net Income VS EBIT VS OCF VS FCFALHRS.PA Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2019 2020 2021 2022 2023 2024 0 -5M -10M -15M -20M -25M

1.2 Ratios

ALHRS's Return On Assets of -8.82% is on the low side compared to the rest of the industry. ALHRS is outperformed by 77.88% of its industry peers.
The Return On Equity of ALHRS (-20.45%) is worse than 78.85% of its industry peers.
Industry RankSector Rank
ROA -8.82%
ROE -20.45%
ROIC N/A
ROA(3y)N/A
ROA(5y)N/A
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ALHRS.PA Yearly ROA, ROE, ROICALHRS.PA Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2019 2020 2021 2022 2023 2024 0 100 200 300

1.3 Margins

The Gross Margin of ALHRS (25.30%) is worse than 67.31% of its industry peers.
In the last couple of years the Gross Margin of ALHRS has declined.
The Profit Margin and Operating Margin are not available for ALHRS so they could not be analyzed.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 25.3%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-12.93%
GM growth 5Y-17.71%
ALHRS.PA Yearly Profit, Operating, Gross MarginsALHRS.PA Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2019 2020 2021 2022 2023 2024 0 20 -20 40 -40 60

More info and screens

3

2. Health

2.1 Basic Checks

ALHRS does not have a ROIC to compare to the WACC, probably because it is not profitable.
ALHRS has no outstanding debt. Therefor its Debt/Equity and Debt/FCF ratios are 0 and belong to the best of the industry.
ALHRS.PA Yearly Shares OutstandingALHRS.PA Yearly Shares OutstandingYearly Shares Outstanding 2019 2020 2021 2022 5M 10M 15M
ALHRS.PA Yearly Total Debt VS Total AssetsALHRS.PA Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2019 2020 2021 2022 20M 40M 60M 80M

2.2 Solvency

ALHRS has an Altman-Z score of 1.18. This is a bad value and indicates that ALHRS is not financially healthy and even has some risk of bankruptcy.
ALHRS's Altman-Z score of 1.18 is on the low side compared to the rest of the industry. ALHRS is outperformed by 63.46% of its industry peers.
ALHRS has a Debt/Equity ratio of 0.45. This is a healthy value indicating a solid balance between debt and equity.
Looking at the Debt to Equity ratio, with a value of 0.45, ALHRS is in line with its industry, outperforming 47.12% of the companies in the same industry.
Industry RankSector Rank
Debt/Equity 0.45
Debt/FCF N/A
Altman-Z 1.18
ROIC/WACCN/A
WACC7.96%
ALHRS.PA Yearly LT Debt VS Equity VS FCFALHRS.PA Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2019 2020 2021 2022 2023 2024 0 20M -20M 40M 60M

2.3 Liquidity

A Current Ratio of 1.46 indicates that ALHRS should not have too much problems paying its short term obligations.
ALHRS has a Current ratio (1.46) which is in line with its industry peers.
ALHRS has a Quick Ratio of 1.42. This is a normal value and indicates that ALHRS is financially healthy and should not expect problems in meeting its short term obligations.
With a decent Quick ratio value of 1.42, ALHRS is doing good in the industry, outperforming 75.96% of the companies in the same industry.
Industry RankSector Rank
Current Ratio 1.46
Quick Ratio 1.42
ALHRS.PA Yearly Current Assets VS Current LiabilitesALHRS.PA Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2019 2020 2021 2022 20M 40M 60M

More info and screens

6

3. Growth

3.1 Past

The earnings per share for ALHRS have decreased strongly by -112.28% in the last year.
ALHRS shows a very negative growth in Revenue. In the last year, the Revenue has decreased by -17.62%.
The Revenue has been growing by 33.81% on average over the past years. This is a very strong growth!
EPS 1Y (TTM)-112.28%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-147.57%
Revenue 1Y (TTM)-17.62%
Revenue growth 3Y33.19%
Revenue growth 5Y33.81%
Sales Q2Q%-37.73%

3.2 Future

The Earnings Per Share is expected to grow by 23.22% on average over the next years. This is a very strong growth
Based on estimates for the next years, ALHRS will show a very strong growth in Revenue. The Revenue will grow by 52.33% on average per year.
EPS Next Y3.63%
EPS Next 2Y19.31%
EPS Next 3Y23.22%
EPS Next 5YN/A
Revenue Next Year-11.27%
Revenue Next 2Y23.74%
Revenue Next 3Y31.07%
Revenue Next 5Y52.33%

3.3 Evolution

The Revenue growth rate is accelerating: in the next years the growth will be better than in the last years.
ALHRS.PA Yearly Revenue VS EstimatesALHRS.PA Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 50M 100M 150M 200M
ALHRS.PA Yearly EPS VS EstimatesALHRS.PA Yearly EPS VS EstimatesYearly EPS VS Estimates 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 0 -0.2 -0.4 -0.6

More info and screens

1

4. Valuation

4.1 Price/Earnings Ratio

ALHRS reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.
Besides the negative Price/Earnings Ratio, also the Forward Price/Earnings Ratio is negative for ALHRS. No positive earnings are expected for the next year.
Industry RankSector Rank
PE N/A
Fwd PE N/A
ALHRS.PA Price Earnings VS Forward Price EarningsALHRS.PA Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 10 20

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
ALHRS.PA Per share dataALHRS.PA EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 1 -1 2 3

4.3 Compensation for Growth

A more expensive valuation may be justified as ALHRS's earnings are expected to grow with 23.22% in the coming years.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y19.31%
EPS Next 3Y23.22%

More info and screens

0

5. Dividend

5.1 Amount

No dividends for ALHRS!.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

HYDROGEN REFUELING SOLUTIONS

EPA:ALHRS (3/7/2025, 7:00:00 PM)

4.09

-0.02 (-0.49%)

Chartmill FA Rating
GICS SectorIndustrials
GICS IndustryGroupCapital Goods
GICS IndustryMachinery
Earnings (Last)N/A N/A
Earnings (Next)04-24 2025-04-24
Inst Owners4.84%
Inst Owner ChangeN/A
Ins Owners66.88%
Ins Owner ChangeN/A
Market Cap62.78M
Analysts85
Price Target6.22 (52.08%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)-16.72%
PT rev (3m)-16.72%
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)-13.27%
EPS NY rev (3m)-13.27%
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)-31.31%
Revenue NY rev (3m)-31.31%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S 2.53
P/FCF N/A
P/OCF N/A
P/B 1.23
P/tB 1.41
EV/EBITDA N/A
EPS(TTM)-0.68
EYN/A
EPS(NY)-0.62
Fwd EYN/A
FCF(TTM)-1.69
FCFYN/A
OCF(TTM)-1.05
OCFYN/A
SpS1.61
BVpS3.32
TBVpS2.91
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -8.82%
ROE -20.45%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM 25.3%
FCFM N/A
ROA(3y)N/A
ROA(5y)N/A
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-12.93%
GM growth 5Y-17.71%
F-Score1
Asset Turnover0.21
Health
Industry RankSector Rank
Debt/Equity 0.45
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr 362.37%
Cap/Sales 39.79%
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 1.46
Quick Ratio 1.42
Altman-Z 1.18
F-Score1
WACC7.96%
ROIC/WACCN/A
Cap/Depr(3y)N/A
Cap/Depr(5y)N/A
Cap/Sales(3y)55.45%
Cap/Sales(5y)37.08%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-112.28%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-147.57%
EPS Next Y3.63%
EPS Next 2Y19.31%
EPS Next 3Y23.22%
EPS Next 5YN/A
Revenue 1Y (TTM)-17.62%
Revenue growth 3Y33.19%
Revenue growth 5Y33.81%
Sales Q2Q%-37.73%
Revenue Next Year-11.27%
Revenue Next 2Y23.74%
Revenue Next 3Y31.07%
Revenue Next 5Y52.33%
EBIT growth 1Y-119.73%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year49.46%
EBIT Next 3Y28.58%
EBIT Next 5YN/A
FCF growth 1Y-24.56%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y-2321.32%
OCF growth 3YN/A
OCF growth 5YN/A